Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-27

FDA Approved: CELECOXIB — Original Application (NIVAGEN PHARMACEUTICALS, INC.)

View source ↗

Summary

The FDA approved NIVAGEN Pharmaceuticals, Inc.'s original application for a generic celecoxib product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

ORIG AP for CELECOXIB (CELECOXIB)